INCR
Intercure Ltd

275
Loading...
Loading...
News
all
press releases
InterCure To Buy ISHI In All-Stock Transaction – Find Out More
The company said that it would acquire ISHI in two phases for a total consideration of 4.92 million shares.
Stocktwits·22d ago
News Placeholder
More News
News Placeholder
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak PR Newswire NEW YORK and HERZLIYA, Israel, Feb. 12, 2025...
PR Newswire·8mo ago
News Placeholder
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ('InterCure' or the 'Company'), the leading vertically integrated medical cannabis company outside of North America, is announcing a new...
Business Wire·1y ago
News Placeholder
InterCure to Participate in Canaccord Genuitys 8th Annual Global Cannabis Conference
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual...
Business Wire·1y ago
News Placeholder
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion
'Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges. read more...
Benzinga·1y ago
News Placeholder
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ('InterCure' or the 'Company') today announced results for the full year ending December 31, 2023. All amounts are expressed in New Israeli Shekels (NIS...
Business Wire·1y ago
News Placeholder
Intercure Ltd. Submits SEC Compliance Report
Intercure (IL:INCR) has released an update. Intercure Ltd., an Israel-based company, has submitted its monthly report to the SEC, affirming its adh...
TipRanks Financial Blog·2y ago
News Placeholder
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ('InterCure' or the Company) today announced preliminary results for the full year of 2023. All amounts are expressed in New Israeli Shekels (NIS), unless...
Business Wire·2y ago
News Placeholder
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ('InterCure' or the 'Company'), the leading medical cannabis company outside of North America, is thrilled to congratulate...
Business Wire·2y ago
News Placeholder
InterCure Provides an Update Regarding Nir Oz Facility
NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in...
Globe Newswire·2y ago

Latest INCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.